The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
The global market for Generic Sterile Injectable was estimated to be worth US$ 51400 million in 2023 and is forecast to a readjusted size of US$ 78570 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
An alternative to the oral delivery mechanism is injectable drug delivery, which easily transports a drug dose through the bloodstream, thereby bypassing first-pass metabolism. There are some medications that would be entirely useless if delivered as capsules, as they would be killed by enzymes that digest food in the stomach. The insulin injection used in diabetes care is an example. Insulin is a protein. Therefore, if given as a tablet, the same enzymes that ferment food in the stomach would be digested. Therefore, as of today, there is no such term as an insulin tablet. Injectable allow the transport, directly into the bloodstream, of drugs manufactured in liquid form. The goal of the delivery of injectable drugs is to optimize patient compliance and reduce the frequency of dose administration without reducing medication efficacy. Due to deep vomiting, unconsciousness or having a cancer lining in the upper part of their dietary canal, it may be impossible to take tablets for certain patients. Therefore, injection options are available for most oral medications. The increasing prevalence of such metabolic disease aids in the overall growth in the sterile injectable market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Sterile Injectable, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Generic Sterile Injectable by region & country, by Type, and by Application.
The Generic Sterile Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Sterile Injectable.
麻豆原创 Segmentation
By Company
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy鈥檚
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
Segment by Type:
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others
Segment by Application
Hospitals
Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Generic Sterile Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Generic Sterile Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Generic Sterile Injectable in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Generic Sterile Injectable Product Introduction
1.2 Global Generic Sterile Injectable 麻豆原创 Size Forecast
1.2.1 Global Generic Sterile Injectable Sales Value (2019-2030)
1.2.2 Global Generic Sterile Injectable Sales Volume (2019-2030)
1.2.3 Global Generic Sterile Injectable Sales Price (2019-2030)
1.3 Generic Sterile Injectable 麻豆原创 Trends & Drivers
1.3.1 Generic Sterile Injectable Industry Trends
1.3.2 Generic Sterile Injectable 麻豆原创 Drivers & Opportunity
1.3.3 Generic Sterile Injectable 麻豆原创 Challenges
1.3.4 Generic Sterile Injectable 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Generic Sterile Injectable Players Revenue Ranking (2023)
2.2 Global Generic Sterile Injectable Revenue by Company (2019-2024)
2.3 Global Generic Sterile Injectable Players Sales Volume Ranking (2023)
2.4 Global Generic Sterile Injectable Sales Volume by Company Players (2019-2024)
2.5 Global Generic Sterile Injectable Average Price by Company (2019-2024)
2.6 Key Manufacturers Generic Sterile Injectable Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Generic Sterile Injectable Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Generic Sterile Injectable
2.9 Generic Sterile Injectable 麻豆原创 Competitive Analysis
2.9.1 Generic Sterile Injectable 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Generic Sterile Injectable Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies
3.1.2 Cytokines
3.1.3 Insulin
3.1.4 Peptide Hormones
3.1.5 Vaccines
3.1.6 Others
3.2 Global Generic Sterile Injectable Sales Value by Type
3.2.1 Global Generic Sterile Injectable Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Generic Sterile Injectable Sales Value, by Type (2019-2030)
3.2.3 Global Generic Sterile Injectable Sales Value, by Type (%) (2019-2030)
3.3 Global Generic Sterile Injectable Sales Volume by Type
3.3.1 Global Generic Sterile Injectable Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Generic Sterile Injectable Sales Volume, by Type (2019-2030)
3.3.3 Global Generic Sterile Injectable Sales Volume, by Type (%) (2019-2030)
3.4 Global Generic Sterile Injectable Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Pharmacies
4.1.3 Online Pharmacies
4.2 Global Generic Sterile Injectable Sales Value by Application
4.2.1 Global Generic Sterile Injectable Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Generic Sterile Injectable Sales Value, by Application (2019-2030)
4.2.3 Global Generic Sterile Injectable Sales Value, by Application (%) (2019-2030)
4.3 Global Generic Sterile Injectable Sales Volume by Application
4.3.1 Global Generic Sterile Injectable Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Generic Sterile Injectable Sales Volume, by Application (2019-2030)
4.3.3 Global Generic Sterile Injectable Sales Volume, by Application (%) (2019-2030)
4.4 Global Generic Sterile Injectable Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Generic Sterile Injectable Sales Value by Region
5.1.1 Global Generic Sterile Injectable Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Generic Sterile Injectable Sales Value by Region (2019-2024)
5.1.3 Global Generic Sterile Injectable Sales Value by Region (2025-2030)
5.1.4 Global Generic Sterile Injectable Sales Value by Region (%), (2019-2030)
5.2 Global Generic Sterile Injectable Sales Volume by Region
5.2.1 Global Generic Sterile Injectable Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Generic Sterile Injectable Sales Volume by Region (2019-2024)
5.2.3 Global Generic Sterile Injectable Sales Volume by Region (2025-2030)
5.2.4 Global Generic Sterile Injectable Sales Volume by Region (%), (2019-2030)
5.3 Global Generic Sterile Injectable Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Generic Sterile Injectable Sales Value, 2019-2030
5.4.2 North America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Generic Sterile Injectable Sales Value, 2019-2030
5.5.2 Europe Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Generic Sterile Injectable Sales Value, 2019-2030
5.6.2 Asia Pacific Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Generic Sterile Injectable Sales Value, 2019-2030
5.7.2 South America Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Generic Sterile Injectable Sales Value, 2019-2030
5.8.2 Middle East & Africa Generic Sterile Injectable Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Generic Sterile Injectable Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Generic Sterile Injectable Sales Value
6.2.1 Key Countries/Regions Generic Sterile Injectable Sales Value, 2019-2030
6.2.2 Key Countries/Regions Generic Sterile Injectable Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Generic Sterile Injectable Sales Value, 2019-2030
6.3.2 United States Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Generic Sterile Injectable Sales Value, 2019-2030
6.4.2 Europe Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Generic Sterile Injectable Sales Value, 2019-2030
6.5.2 China Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.5.3 China Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Generic Sterile Injectable Sales Value, 2019-2030
6.6.2 Japan Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Generic Sterile Injectable Sales Value, 2019-2030
6.7.2 South Korea Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Generic Sterile Injectable Sales Value, 2019-2030
6.8.2 Southeast Asia Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Generic Sterile Injectable Sales Value, 2019-2030
6.9.2 India Generic Sterile Injectable Sales Value by Type (%), 2023 VS 2030
6.9.3 India Generic Sterile Injectable Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.1.4 3M Generic Sterile Injectable Product Offerings
7.1.5 3M Recent Development
7.2 Baxter Inc
7.2.1 Baxter Inc Company Information
7.2.2 Baxter Inc Introduction and Business Overview
7.2.3 Baxter Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Inc Generic Sterile Injectable Product Offerings
7.2.5 Baxter Inc Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Fresenius Kabi Generic Sterile Injectable Product Offerings
7.3.5 Fresenius Kabi Recent Development
7.4 Pfizer/Hospira
7.4.1 Pfizer/Hospira Company Information
7.4.2 Pfizer/Hospira Introduction and Business Overview
7.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer/Hospira Generic Sterile Injectable Product Offerings
7.4.5 Pfizer/Hospira Recent Development
7.5 Novartis/Sandoz
7.5.1 Novartis/Sandoz Company Information
7.5.2 Novartis/Sandoz Introduction and Business Overview
7.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Novartis/Sandoz Generic Sterile Injectable Product Offerings
7.5.5 Novartis/Sandoz Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Introduction and Business Overview
7.6.3 Teva Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teva Generic Sterile Injectable Product Offerings
7.6.5 Teva Recent Development
7.7 Hikma
7.7.1 Hikma Company Information
7.7.2 Hikma Introduction and Business Overview
7.7.3 Hikma Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hikma Generic Sterile Injectable Product Offerings
7.7.5 Hikma Recent Development
7.8 Sun Pharma
7.8.1 Sun Pharma Company Information
7.8.2 Sun Pharma Introduction and Business Overview
7.8.3 Sun Pharma Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sun Pharma Generic Sterile Injectable Product Offerings
7.8.5 Sun Pharma Recent Development
7.9 Dr. Reddy鈥檚
7.9.1 Dr. Reddy鈥檚 Company Information
7.9.2 Dr. Reddy鈥檚 Introduction and Business Overview
7.9.3 Dr. Reddy鈥檚 Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Dr. Reddy鈥檚 Generic Sterile Injectable Product Offerings
7.9.5 Dr. Reddy鈥檚 Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Introduction and Business Overview
7.10.3 Mylan Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Generic Sterile Injectable Product Offerings
7.10.5 Mylan Recent Development
7.11 AstraZeneca Plc
7.11.1 AstraZeneca Plc Company Information
7.11.2 AstraZeneca Plc Introduction and Business Overview
7.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.11.4 AstraZeneca Plc Generic Sterile Injectable Product Offerings
7.11.5 AstraZeneca Plc Recent Development
7.12 Merck & Co., Inc
7.12.1 Merck & Co., Inc Company Information
7.12.2 Merck & Co., Inc Introduction and Business Overview
7.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Merck & Co., Inc Generic Sterile Injectable Product Offerings
7.12.5 Merck & Co., Inc Recent Development
7.13 Hellberg Safety Ab
7.13.1 Hellberg Safety Ab Company Information
7.13.2 Hellberg Safety Ab Introduction and Business Overview
7.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Offerings
7.13.5 Hellberg Safety Ab Recent Development
8 Industry Chain Analysis
8.1 Generic Sterile Injectable Industrial Chain
8.2 Generic Sterile Injectable Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Generic Sterile Injectable Sales Model
8.5.2 Sales Channel
8.5.3 Generic Sterile Injectable Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy鈥檚
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
听
听
*If Applicable.